Found 25 matching trials
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
PHASE2This study will investigate the safety and effectiveness of combination reg...
Status
Active Not Recruiting
Location
Bong County Hospital
Host Response to Infection and Treatment in Lymphatic Filarial Disease in India
N/APatients admitted on this protocol will have, or be suspected of having, on...
Location
Tuberculosis Research Centre
Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis
PHASE4Background:
* Loa loa is a small worm that infects people in West and Cent...
Location
Filariasis and other Tropical Diseases Research Center
Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
PHASE2This study will determine if a combination of 3 drugs used to treat the inf...
Location
Papua New Guinean Institute for Medical Research
Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNG
N/AThe standard regimen for elimination of lymphatic filariasis (LF) in PNG is...
Location
Papua New Guinean Institute for Medical Research
Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
PHASE2This study is conducted in Kerala, India. It will determine whether a new t...
Location
Filariasis Chemotherapy Unit (FCU), T.D. Medical Hospital
Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis
N/AThis study, sponsored by the National Institutes of Health and the Tubercul...
Location
Government General Hospital
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
PHASE2Diethylcarbamazine citrate (DEC) treatment of Loa loa infection is complica...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Lymphatic Filariasis (LF) in Ivory Coast
NAThe recommended treatment for elimination of LF in sub-Saharan Africa is an...
Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)
PHASE1The study will be an open label cohort study with 2 two-treatment groups 2)...
Location
Agboville District Hospital